ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Illinois » Otolaryngology

Top Otolaryngology Prescribers in Illinois

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
MISHAIL SHAPIRO D.O.

Otolaryngology

1,724

$78.8K

414
356 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

6%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 20%

$46
Average prescription price

Avg: $50

CHARLY NGUYEN M.D.

Otolaryngology

1,382

$38.5K

405
283 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

10%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

6%
prescriptions for brand name drugs

Avg: 20%

$28
Average prescription price

Avg: $50

KEITH BONACQUISTI MD

Otolaryngology

1,214

$70.5K

214
151 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

31%
prescriptions for brand name drugs

Avg: 20%

$58
Average prescription price

Avg: $50

JEFFREY FIERSTEIN M.D.

Otolaryngology

1,012

$43.8K

453
321 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

8%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 20%

$43
Average prescription price

Avg: $50

PETER HAUSLEIN MD

Otolaryngology

935

$21.3K

396
360 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

10%
prescriptions for brand name drugs

Avg: 20%

$23
Average prescription price

Avg: $50

STEVEN HORWITZ M.D.

Otolaryngology

880

$33.7K

283
245 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

15%
prescriptions for brand name drugs

Avg: 20%

$38
Average prescription price

Avg: $50

BENJAMIN JOHNSON MD

Otolaryngology

869

$42.8K

282
232 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

14%
prescriptions for brand name drugs

Avg: 20%

$49
Average prescription price

Avg: $50

CHANG-YANG WANG M.D.

Otolaryngology

868

$49.1K

174
153 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

13%
prescriptions for brand name drugs

Avg: 20%

$57
Average prescription price

Avg: $50

SUNG CHUNG MD

Otolaryngology

853

$47.7K

178
152 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

8%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

36%
prescriptions for brand name drugs

Avg: 20%

$56
Average prescription price

Avg: $50

MICHAEL FRIEDMAN M.D.

Otolaryngology

796

$55.1K

175
141 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 20%

$69
Average prescription price

Avg: $50

CARL LEE M.D.

Otolaryngology

793

$34.6K

271
224 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

8%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

15%
prescriptions for brand name drugs

Avg: 20%

$44
Average prescription price

Avg: $50

DAVID MANN M.D.

Otolaryngology

781

$35.8K

271
207 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

14%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 20%

$46
Average prescription price

Avg: $50

T VENKATESAN M.D.

Otolaryngology

776

$53.5K

265
189 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

17%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

18%
prescriptions for brand name drugs

Avg: 20%

$69
Average prescription price

Avg: $50

DAVID NISSAN MD

Otolaryngology

760

$34.2K

321
265 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

15%
prescriptions for brand name drugs

Avg: 20%

$45
Average prescription price

Avg: $50

JAMES FERNANDEZ M.D.

Otolaryngology

759

$34.6K

353
266 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

7%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 20%

$46
Average prescription price

Avg: $50

JOSEPH DONZELLI M.D.

Otolaryngology

719

$41.3K

167
133 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

65%
prescriptions for brand name drugs

Avg: 20%

$57
Average prescription price

Avg: $50

JACQUELYNNE COREY MD

Otolaryngology

689

$77.4K

101
53 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

50%
prescriptions for brand name drugs

Avg: 20%

$112
Average prescription price

Avg: $50

ERIK NELSON MD

Otolaryngology

673

$23.9K

199
159 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

16%
prescriptions for brand name drugs

Avg: 20%

$36
Average prescription price

Avg: $50

JOSEPH ALLEGRETTI M.D.

Otolaryngology

663

$41.6K

181
132 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 20%

$63
Average prescription price

Avg: $50

JOHN ORTEGA MD

Otolaryngology

649

$39.5K

239
172 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

12%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 20%

$61
Average prescription price

Avg: $50

NEAL LOFCHY M.D.

Otolaryngology

647

$52.7K

137
115 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

30%
prescriptions for brand name drugs

Avg: 20%

$81
Average prescription price

Avg: $50

ROBERT THOMAS M.D.

Otolaryngology

647

$20.7K

201
173 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

11%
prescriptions for brand name drugs

Avg: 20%

$32
Average prescription price

Avg: $50

ANDREW SCHUBKEGEL MD

Otolaryngology

645

$44K

171
151 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 6%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 20%

$68
Average prescription price

Avg: $50

JAY DUTTON M.D.

Otolaryngology

645

$45.6K

162
131 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

31%
prescriptions for brand name drugs

Avg: 20%

$71
Average prescription price

Avg: $50

PHILIP GARCIA M.D.

Otolaryngology

645

$15K

200
156 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

8%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

9%
prescriptions for brand name drugs

Avg: 20%

$23
Average prescription price

Avg: $50

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank